Colorectal Cancer Caused by Zantac

Zantac Lawsuits

Since the popular heartburn drug Zantac was removed from the marketplace last year, scientists are finding more evidence of the potential dangers of the drug due specifically due to the chemical substance ranitidine present in Zantac.

For over a year, the FDA has been investigating potential contamination of some medications with N-nitrosodimethylamine (NDMA), a known carcinogen. Making matters worse, theFDA has found N-nitrosodimethylamine (NDMA) levels in some ranitidine products (such as Zantac) increase with time and temperature posing a risk to significant risk to consumers.

Serving Clients Across the Nation

Zantac & Colorectal Cancer

There have already been documented cases of Zantac users contracting colorectal cancer as a result of the carcinogens found in the product. The World Health Organization (WHO) has positively associated NDMA with colorectal cancer.

A 1999 medical study determined a link between colorectal cancer and exposure to NDMA concluding that “Our results are in line with the idea that N‐nitroso compounds can induce colorectal cancer in humans.”

In July 2018, the FDA alerted healthcare professionals and patients of a voluntary recall of many valsartan-containing medications. The agency continued its investigation of the issue and released many additional updates concerning valsartan recalls over the subsequent months.

The American Cancer Society estimate that about 1 in 21 men and 1 in 23 women in the United States will develop colorectal cancer during their lifetime. It is the second leading cause of cancer death in women, and the third for men.

Memorial Sloan Kettering Cancer Center Logo American Cancer Society Logo

Symptoms of colorectal cancer include:

  • changes in bowel habits
  • diarrhea or constipation
  • a feeling that the bowel does not empty properly after a bowel movement
  • blood in feces that makes stools look black
  • bright red blood coming from the rectum
  • pain and bloating in the abdomen
  • a feeling of fullness in the abdomen, even after not eating for a while.
  • fatigue or tiredness
  • unexplained weight loss
  • a lump in the abdomen or the back passage felt by your doctor
  • unexplained iron deficiency in men, or in women after menopause

If you have been a Zantac user and have any of these symptoms, consult your physician.

Get Started On Your Case Today

You may be able to file a Zantac colorectal cancer lawsuit if you developed colorectal cancer while consuming Zantac for a prolonged period of time. Use the contact form on this page for a free case evaluation by one of our experienced dangerous drug attorneys. You may also call our office directly at (888) 260-0473 to discuss your Zantac cancer lawsuit and possible settlement. At Rheingold Giuffra Ruffo & Plotkin LLP, our New York defective drug lawyers handle cases directly and do not refer them to other firms.

Verdicts & Settlements

  • Auto Accident $2,750,000
  • Biopsy Resulting In Blindness $2,500,000
  • Birth Injury $1,000,000
  • Brain Damage $12,000,000
  • Brain Damage of Infant $1,000,000
  • Brain Damage of Infant $2,100,000
  • Cancer Misdiagnosis $2,500,000
  • Cardiovascular Injury $2,200,000
  • Cataract Surgery Complication $1,700,000
  • Child's Hand Injury $9,000,000
/

What Sets Us Apart

  • Over 2 Billion Recovered

    We fight tirelessly to deliver results and we are not afraid to go to trial.

  • Recognized Leaders

    We are leaders and educators in legal issues involving personal injury, medical malpractice, and product liability.

  • 50+ Years of Experience

    We have the experience to handle your case all while providing individualized attention.

Request Your Free Consultation Today

Fill Out the Form Below to Get Started or Call Us At (888) 260-0473.

  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.